Timing Is Everything: CAR T for Follicular Lymphoma
CAR T-cell therapy is the best option for patients with relapsed/refractory follicular lymphoma, even though it comes with serious side effects.
Stay updated with breaking news from Great Debates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CAR T-cell therapy is the best option for patients with relapsed/refractory follicular lymphoma, even though it comes with serious side effects.
Note: this blog post has been put together over the course of the week I followed the happenings at the conference virtually. Should recordings of the Great Debates and possibly Union Symposia mentioned below, be released sometime after the conference ends, I'll include links to the ones I participated in.
Explore the pivotal moments that have defined American television history, from iconic royal weddings to historic moon landings.
The emerging CDH6-directed antibody-drug conjugate raludotatug deruxtecan had a manageable safety profile, generated pharmacokinetic activity, and produced early evidence of clinical response in patients with heavily pretreated, platinum-resistant ovarian cancer.
The For The Win staff debate the best (Nashville) and worst (O’Hare) airports in the United States in a heated roundtable.